Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer | Scientific Reports - Nature.com

Scientific Reports - Aptamer-antibody hybrid ELONA that uses hybridization chain reaction to detect a urinary biomarker EN2 for bladder and prostate cancer

Materials Genomic DNA of EN2 was purchased from Thermo Fisher Scientific (USA). The pET28a plasmid was purchased from Novagen (Germany). Nucleospin Gel and PCR Clean-up/Plasmid EasyPure kit were acq… [+7947 chars]

full article...